Drug screening identified gemcitabine inhibiting hepatitis E virus by inducing interferon-like response via activation of STAT1 phosphorylation

Yunlong Li; Pengfei Li; Yang Li; Ruyi Zhang; Peifa Yu; Z Ma; DE Kainov; Rob de Man; Maikel Peppelenbosch; Qiuwei Pan

doi:10.1016/j.antiviral.2020.104967

Drug screening identified gemcitabine inhibiting hepatitis E virus by inducing interferon-like response via activation of STAT1 phosphorylation

Yunlong Li, Pengfei Li, Yang Li, Ruyi Zhang, Peifa Yu, Z Ma, DE Kainov, Rob de Man, Maikel Peppelenbosch, Qiuwei Pan

Gastroenterology & Hepatology

Research output: Contribution to journal › Article › Academic › peer-review

14 Citations (Scopus)

5 Downloads (Pure)

Original language	English
Article number	104967
Journal	Antiviral Research
Volume	184
DOIs	https://doi.org/10.1016/j.antiviral.2020.104967
Publication status	Published - 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.antiviral.2020.104967

Repub_133780_O-A.pdfFinal published version, 6.45 MB

http://hdl.handle.net/1765/133780

Cite this

@article{c761835e94634837afd7ac106ca02486,

title = "Drug screening identified gemcitabine inhibiting hepatitis E virus by inducing interferon-like response via activation of STAT1 phosphorylation",

author = "Yunlong Li and Pengfei Li and Yang Li and Ruyi Zhang and Peifa Yu and Z Ma and DE Kainov and {de Man}, Rob and Maikel Peppelenbosch and Qiuwei Pan",

year = "2020",

doi = "10.1016/j.antiviral.2020.104967",

language = "English",

volume = "184",

journal = "Antiviral Research",

issn = "0166-3542",

publisher = "Elsevier",

}

TY - JOUR

T1 - Drug screening identified gemcitabine inhibiting hepatitis E virus by inducing interferon-like response via activation of STAT1 phosphorylation

AU - Li, Yunlong

AU - Li, Pengfei

AU - Li, Yang

AU - Zhang, Ruyi

AU - Yu, Peifa

AU - Ma, Z

AU - Kainov, DE

AU - de Man, Rob

AU - Peppelenbosch, Maikel

AU - Pan, Qiuwei

PY - 2020

Y1 - 2020

U2 - 10.1016/j.antiviral.2020.104967

DO - 10.1016/j.antiviral.2020.104967

M3 - Article

VL - 184

JO - Antiviral Research

JF - Antiviral Research

SN - 0166-3542

M1 - 104967

ER -